世界の分子分光法市場の規模、シェア、トレンド分析レポート – 業界の概要と2031年までの予測

Get Exclusive Sample PDF of this Report Here

分子分光法市場分析

分子分光法市場は、急速な技術向上と、製薬、ヘルスケア、環境試験などの業界での需要増加により、急速に拡大しています。市場の成長は、分析の精度と機能を変革した強化された近赤外線 (NIR) およびラマン分光法技術などの進歩によって推進されています。これらの進歩により、分子分析はより正確かつ効率的になり、製薬業界の医薬品開発や品質管理からヘルスケアの高度な診断ツールまで、幅広いアプリケーションが促進されます。

分子分光法の市場規模

世界の分子分光法の市場規模は、2023年に774万米ドルと評価され、2024年から2031年の予測期間中に7.3%のCAGRで成長し、2031年には1,361万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

分子分光法の市場動向

「環境基準の改善への重点化」

環境基準の改善に対する世界的な注目と、正確で信頼性の高い試験手順に対する需要が、分子分光法市場の成長を牽引しています。分子分光法、特にラマン分光法と近赤外線 (NIR) 分光法は、空気、水、土壌中の汚染物質を特定して測定する上で重要な役割を果たします。たとえば、ラマン分光法は、化学汚染物質を特定し、水質をリアルタイムで監視するために広く使用されており、環境コンプライアンスに重要なデータを提供します。さまざまな分野の利害関係者が、規制要件を満たし、環境問題を管理するための高度な分析ソリューションを求めているため、分子分光法の市場はさらに拡大しています。

レポートの範囲と分子分光法市場のセグメンテーション     

Get Exclusive Sample PDF of this Report Here

分子分光法市場の定義

分子分光法は分光法の分野であり、電磁放射と分子の相互作用を研究します。分子がさまざまな波長で光を吸収、放出、または散乱する方法に焦点を当て、分子の構造、構成、および動作に関する詳細な情報を提供します。これらの相互作用を分析することで、分子分光法は分子の特性を特定し、物質の特性を評価し、さまざまな化学プロセスを理解するのに役立ちます。

分子分光法市場の動向

ドライバー

• 医薬品における分子分光法の需要増加

The pharmaceutical industry relies heavily on molecular spectroscopy for drug development, quality control, and regulatory compliance. For instance, Raman spectroscopy is used to analyze the molecular composition of drug formulations, ensuring the correct drug compound and verifying its stability over time. This technique helps identify and quantify active pharmaceutical ingredients (APIs) and excipients, ensuring that formulations meet strict regulatory standards and maintain consistent quality. Such demand for rigorous analytical methods in drug development and manufacturing propels the growth of the molecular spectroscopy market.

• Rising Use in the Biotechnology Industry

The increasing utilization of molecular spectroscopy in the biotechnology industries is significantly boosting the market's growth rate. For instance, the Thermo Fisher Scientific Q Exactive HF-X Mass Spectrometer is widely used in pharmaceutical research for its high-resolution capabilities, enabling precise identification of complex drug molecules and metabolites. In biotechnology, molecular spectroscopy aids in the characterization of biomolecules and the optimization of bioprocesses. Such growing reliance on advanced spectroscopic techniques reflects a broader trend towards more sophisticated analytical methods, driving substantial growth in the molecular spectroscopy market.

Opportunities

• Research and Development Investments

Increased investments in R&D across sectors such as materials science, nanotechnology, and chemical engineering are significantly fueling the demand for advanced spectroscopy tools, presenting a substantial opportunity for the molecular spectroscopy market. For instance, Wipro GE Healthcare has announced a USD 960 million investment in its manufacturing and R&D facilities in India, underscoring the growing emphasis on developing sophisticated analytical technologies. This investment reflects a broader trend where major players are channelling substantial resources into enhancing their capabilities, driving advancements in molecular spectroscopy.

• Advancements in Spectroscopy Technology

Innovations such as the integration of machine learning algorithms with molecular spectroscopy are transforming data analysis and interpretation, leading to significant advancements in the field. By applying machine learning techniques to spectral data, researchers can achieve more precise and automated analysis, reducing the time and complexity traditionally associated with data interpretation. For instance, machine learning algorithms can identify subtle spectral patterns and correlations that might be missed by manual analysis, enhancing the accuracy of Fourier-transform infrared (FTIR) and Raman spectroscopy. Such synergy streamlines the process and also increases the efficiency and value of these techniques across diverse applications, such as material science and pharmaceuticals. As a result, the combination of machine learning with molecular spectroscopy represents a transformative opportunity for advancing research and development across multiple industries.

Restraints/Challenges

• Stringent regulations

In Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) imposes stringent regulations on molecular spectroscopy equipment used in pharmaceutical applications, such as those outlined in the Pharmaceutical Affairs Law (PAL) and the Good Manufacturing Practice (GMP) guidelines. Compliance with PMDA guidelines requires extensive validation procedures, detailed documentation, and adherence to specific quality standards for molecular spectroscopy. For instance, spectroscopy devices must undergo rigorous testing to ensure they meet the accuracy and reliability standards set forth by the PMDA. Such regulations mandate thorough performance validation, including detailed calibration and verification processes, which can lead to substantial additional costs and administrative efforts for manufacturers.

• High Cost Of Spectroscopy Instruments

The initial investment required for advanced systems, such as high-resolution FTIR or NMR spectrometers, can be prohibitively expensive. These sophisticated instruments, essential for precise and reliable molecular analysis, often come with high costs that may restrict spectroscopy instruments accessibility, particularly for smaller laboratories, research institutions, and organizations with constrained budgets. Such financial barriers can slow down the adoption of cutting-edge spectroscopy technologies and hinder their integration into broader research and industrial applications. Consequently, the high cost of equipment can restrict market growth by narrowing the pool of potential users and slowing the advancement of new technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Molecular Spectroscopy Market Scope

The market is segmented on the basis of technology, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Nuclear Magnetic Resonance Spectroscopy
• UV-Visible Spectroscopy
• Infrared Spectroscopy
  • Mid-Wave Infrared Spectroscopy
  • Short-Wave Infrared Spectroscopy
  • Far-Wave Infrared Spectroscopy
  • Benchtop
  • Infrared Microscopy
  • Portable & Handheld
  • Hyphenated
  • Terahertz
• Near-Infrared Spectroscopy
  • Scanning Near-Infrared Spectroscopy
  • Fourier-Transform Near-Infrared Spectroscopy
  • Filter-Nir Spectroscopy/Acoustic-Optical Tunable Filter-Nir Spectroscopy
• Colour Measurement Spectroscopy
• Raman Spectroscopy
  • Surface-Enhanced Raman Scattering
  • Tip-Enhanced Raman Scattering
  • Micro-Raman Spectroscopy
  • Probe-Based Raman Spectroscopy
  • Ft-Raman Spectroscopy
• Other Technologies

Application

• Pharmaceutical Applications
• Food and Beverage Testing
• Biotechnology and Biopharmaceutical Applications
• Environmental Testing
• Academic Research
• Other Applications

Molecular Spectroscopy Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, technology, and application.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the global molecular spectroscopy market due to its robust healthcare infrastructure, the significant presence of key industry players, and a large patient population seeking advanced cancer diagnostics. The regions strong base of healthcare facilities further supports its dominance, while ongoing investments in research and development drive continued innovation and growth.

Asia-Pacific is projected to experience substantial growth from 2024 to 2031, driven by increased government initiatives to enhance healthcare, heightened health awareness among the population, and a rising demand for advanced medical technology. The region's large population and growing need for high-quality healthcare further contribute to this expected growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Molecular Spectroscopy Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Molecular Spectroscopy Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific Inc. (U.S.)
• Bruker (U.S.)
• PerkinElmer (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Eurofins Scientific (Luxembourg)
• Danaher Corporation (U.S.)
• Merck KGaA (Germany)
• Siemens Medical Solutions USA, Inc.
• Medtronic (Ireland)
• ABB (Switzerland)
• B&W Tek. (U.S.)
• ROBERT BOSCH TOOL CORPORATION (U.S.)
• Hamamatsu Photonics K.K. (Japan)
• HORIBA, Ltd. (Japan)
• JASCO INTERNATIONAL CO., LTD.(Japan)
• JEOL Ltd. (Japan)
• Endress+Hauser Group Services AG (Switzerland)
• Metrohm AG  (Switzerland)
• Montana Instruments Corporation. (U.S.)
• Teledyne Technologies (U.S.)
• Renishaw plc. (U.K.)
• Shimadzu Corporation (Japan)

Latest Developments in Molecular Spectroscopy Market

• In April 2023, Edinburgh Instruments unveiled its latest innovation, the IR5 benchtop FTIR Spectrometer, developed and produced at their global headquarters in Scotland. This marks the debut of the Edinburgh Instruments brand in the realm of Fourier Transform Infrared (FTIR) spectroscopy, complementing their established expertise in Raman, fluorescence, and UV-Vis absorption spectroscopies. The IR5 is a cutting-edge, high-performance FTIR instrument that offers the flexibility of being equipped with either a second detector or Fourier Transform Photoluminescence (FT-PL) capability, making it a versatile addition to their product lineup.
• 2024年3月、医薬品ライフサイクル全体にわたってカスタマイズされたAPIおよびCDMOサービスを提供する大手プロバイダーであるLGM Pharmaは、その機能の大幅な強化を発表しました。同社は分析試験サービス（ATS）の提供を50％拡大し、この独立したサービスに200万米ドル以上を投資しています。さらに、LGM Pharmaは、契約開発製造（CDMO）ポートフォリオに新しい坐剤製造機能を導入しています。

SKU-1744